Omid Gholizadeh

1.2k total citations · 2 hit papers
31 papers, 808 citations indexed

About

Omid Gholizadeh is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Omid Gholizadeh has authored 31 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Omid Gholizadeh's work include COVID-19 Clinical Research Studies (5 papers), Mosquito-borne diseases and control (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Omid Gholizadeh is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Mosquito-borne diseases and control (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Omid Gholizadeh collaborates with scholars based in Iran, Iraq and Türkiye. Omid Gholizadeh's co-authors include Saman Yasamineh, Hamed Afkhami, Mehdi Dadashpour, Hesam Ghafouri Kalajahi, Yalda Yazdani, Majid Eslami, Somayeh Vafaei, Kamyar Nasiri, Sara Amini and Renzon Daniel Cosme Pecho and has published in prestigious journals such as International Journal of Pharmaceutics, Molecular Neurobiology and Stem Cell Research & Therapy.

In The Last Decade

Omid Gholizadeh

29 papers receiving 799 citations

Hit Papers

A state-of-the-art review on the recent advances of nioso... 2022 2026 2023 2024 2022 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omid Gholizadeh Iran 17 325 125 110 109 83 31 808
Saman Yasamineh Iran 21 483 1.5× 156 1.2× 124 1.1× 176 1.6× 101 1.2× 42 1.2k
Sara Scutera Italy 20 273 0.8× 98 0.8× 120 1.1× 34 0.3× 67 0.8× 45 937
Xiaoyong Yuan China 18 277 0.9× 100 0.8× 156 1.4× 50 0.5× 88 1.1× 78 1.0k
Eugenio Hardy Cuba 20 682 2.1× 91 0.7× 148 1.3× 52 0.5× 42 0.5× 61 1.1k
Songyin Huang China 19 873 2.7× 141 1.1× 84 0.8× 229 2.1× 15 0.2× 33 1.5k
Takashi Oono Japan 20 332 1.0× 230 1.8× 160 1.5× 81 0.7× 15 0.2× 60 1.2k
Aayushi Uberoi United States 14 241 0.7× 45 0.4× 338 3.1× 70 0.6× 30 0.4× 22 936
Elham Mohit Iran 17 402 1.2× 104 0.8× 101 0.9× 63 0.6× 69 0.8× 39 804
Ali Aghebati‐Maleki Iran 16 423 1.3× 91 0.7× 74 0.7× 124 1.1× 24 0.3× 30 1.2k
Lingling Sun China 15 261 0.8× 53 0.4× 112 1.0× 47 0.4× 25 0.3× 31 776

Countries citing papers authored by Omid Gholizadeh

Since Specialization
Citations

This map shows the geographic impact of Omid Gholizadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omid Gholizadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omid Gholizadeh more than expected).

Fields of papers citing papers by Omid Gholizadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omid Gholizadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omid Gholizadeh. The network helps show where Omid Gholizadeh may publish in the future.

Co-authorship network of co-authors of Omid Gholizadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Omid Gholizadeh. A scholar is included among the top collaborators of Omid Gholizadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omid Gholizadeh. Omid Gholizadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allela, Omer Qutaiba B., et al.. (2024). Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma. Virology Journal. 21(1). 17–17. 12 indexed citations
2.
Muzammil, Khursheed, et al.. (2024). Recent Advances in Crimean-Congo Hemorrhagic Fever Virus Detection, Treatment, and Vaccination: Overview of Current Status and Challenges. Biological Procedures Online. 26(1). 20–20. 9 indexed citations
3.
Yasamineh, Saman, et al.. (2024). Recent Advances in the Role of Different Nanoparticles in the Various Biosensors for the Detection of the Chikungunya Virus. Molecular Biotechnology. 67(1). 54–79. 12 indexed citations
4.
Gholizadeh, Omid, Saman Yasamineh, Parastoo Hosseini, et al.. (2023). The role of non-coding RNAs in the diagnosis of different stages (HCC, CHB, OBI) of hepatitis B infection. Microbial Pathogenesis. 176. 105995–105995. 14 indexed citations
5.
Hazrati, Ebrahim, et al.. (2023). Cardio-Pulmonary Histopathology with Clinical Correlations of Deceased Patients with COVID-19: A Case Series in Tehran, Iran. Archives of Iranian Medicine. 26(5). 252–260.
6.
Saadh, Mohamed J., et al.. (2023). Progress and prospects on vaccine development against monkeypox infection. Microbial Pathogenesis. 180. 106156–106156. 45 indexed citations
7.
Ahmed, Hanan Hassan, et al.. (2023). The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection. Virology Journal. 20(1). 222–222. 22 indexed citations
8.
Gholizadeh, Omid, et al.. (2023). Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination. Canadian Journal of Infectious Diseases and Medical Microbiology. 2023(1). 4263309–4263309. 37 indexed citations
9.
Vafaei, Somayeh, et al.. (2023). The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases. Cell Communication and Signaling. 21(1). 20–20. 81 indexed citations
10.
Yasamineh, Saman, et al.. (2023). The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells. Cancer Cell International. 23(1). 250–250. 17 indexed citations
11.
Yasamineh, Saman, et al.. (2023). Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. Cancer Cell International. 23(1). 284–284. 23 indexed citations
12.
Ortiz, Geovanny Genaro Reiván, et al.. (2023). A state-of-the-art review on the MicroRNAs roles in hematopoietic stem cell aging and longevity. Cell Communication and Signaling. 21(1). 85–85. 16 indexed citations
13.
Gholizadeh, Omid, et al.. (2023). Review of the evidence of the effects of human papillomavirus infection and Gardnerella vaginalis, and their co-infection on infertility. Microbial Pathogenesis. 175. 105980–105980. 11 indexed citations
14.
Nasiri, Kamyar, et al.. (2023). Spotlight on the impact of viral infections on Hematopoietic Stem Cells (HSCs) with a focus on COVID-19 effects. Cell Communication and Signaling. 21(1). 103–103. 18 indexed citations
15.
Nasiri, Kamyar, et al.. (2023). Recent advances in metal nanoparticles to treat periodontitis. Journal of Nanobiotechnology. 21(1). 283–283. 86 indexed citations breakdown →
16.
17.
Poortahmasebi, Vahdat, Ahmad Nejati, Mohammad Foad Abazari, et al.. (2022). Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–13. 3 indexed citations
18.
Gholizadeh, Omid, Saman Yasamineh, Hamed Afkhami, et al.. (2022). Comprehensive Investigations Relationship Between Viral Infections and Multiple Sclerosis Pathogenesis. Current Microbiology. 80(1). 15–15. 22 indexed citations
19.
Gholizadeh, Omid, et al.. (2022). Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. Virology Journal. 19(1). 206–206. 26 indexed citations
20.
Gholizadeh, Omid, et al.. (2022). Recent advances in treatment Crimean–Congo hemorrhagic fever virus: A concise overview. Microbial Pathogenesis. 169. 105657–105657. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026